0.8998
Precedente Chiudi:
$0.9334
Aprire:
$0.94
Volume 24 ore:
746.87K
Relative Volume:
0.91
Capitalizzazione di mercato:
$45.25M
Reddito:
-
Utile/perdita netta:
$-56.85M
Rapporto P/E:
-0.5772
EPS:
-1.559
Flusso di cassa netto:
-
1 W Prestazione:
-9.11%
1M Prestazione:
-51.62%
6M Prestazione:
-40.01%
1 anno Prestazione:
-73.38%
Fractyl Health Inc Stock (GUTS) Company Profile
Nome
Fractyl Health Inc
Settore
Industria
Telefono
781-902-8800
Indirizzo
3 VAN DE GRAAFF DRIVE, BURLINGTON
Confronta GUTS con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
GUTS
Fractyl Health Inc
|
0.8998 | 69.23M | 0 | -56.85M | 0 | -1.559 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-08-28 | Iniziato | Ladenburg Thalmann | Buy |
2024-02-28 | Iniziato | Evercore ISI | Outperform |
2024-02-27 | Iniziato | BofA Securities | Buy |
2024-02-27 | Iniziato | Morgan Stanley | Overweight |
Fractyl Health Inc Borsa (GUTS) Ultime notizie
Order flow analysis tools used on Fractyl Health Inc.Trend Reversal & Stepwise Trade Execution Plans - Newser
Fractyl Health Inc. stock outlook for YEARFed Meeting & Daily Oversold Bounce Ideas - Newser
Will earnings trigger a reversal in Fractyl Health Inc.July 2025 Sentiment & Stepwise Trade Execution Plans - Newser
What to do if you’re stuck in Fractyl Health Inc.2025 Macro Impact & Short-Term High Return Strategies - Newser
Century Therapeutics shares rise 1.89% premarket after Fractyl Health expands its board of directors. - AInvest
Fractyl Health appoints two new directors and announces board resignation - Investing.com
Fractyl Health appoints Christopher Thompson, Ian Sheffield to board - TipRanks
Fractyl Health's Strategic Leadership Expansion and Capital Raise Signal Readiness for Market Breakthrough in Obesity and T2D Therapeutics - AInvest
Fractyl Health, Inc. Appoints Christopher Thompson, M.D. and Ian Sheffield to Board of Directors Amid Expansion of Metabolic Therapeutics Development - Quiver Quantitative
Harvard Endoscopy Pioneer and Healthcare Veteran Join Fractyl Health Board Ahead of Critical Trials - Stock Titan
Short interest data insights for Fractyl Health Inc.2025 AllTime Highs & Daily Profit Focused Screening - Newser
How high can Fractyl Health Inc. stock goWeekly Investment Recap & Step-by-Step Swing Trade Plans - Newser
Can swing trading help recover from Fractyl Health Inc. lossesPortfolio Growth Summary & Low Risk Growth Stock Ideas - Newser
Sentiment analysis tools applied to Fractyl Health IncChart Signals & Daily Entry Point Alerts - Newser
How to interpret RSI for Fractyl Health Inc. stock2025 Investor Takeaways & Real-Time Chart Breakout Alerts - Newser
What is the dividend yield of Fractyl Health Inc.2025 Price Action Summary & Long-Term Capital Growth Ideas - khodrobank.com
What’s next for Fractyl Health Inc. stock priceMarket Trend Summary & Technical Confirmation Trade Alerts - Newser
What’s the profit margin of Fractyl Health Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스
Sentiment analysis tools applied to Fractyl Health Inc.July 2025 Setups & Consistent Growth Equity Picks - Newser
Institutional Tools Highlight Unusual Flow in Fractyl Health Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
Can Fractyl Health Inc. recover in the next quarterTrade Risk Report & Low Drawdown Trading Techniques - Newser
Why Fractyl Health Inc. is moving todayEarnings Trend Report & Daily Growth Stock Tips - Newser
Is Fractyl Health Inc. a turnaround storyJuly 2025 Price Swings & Stepwise Swing Trade Plans - khodrobank.com
Analyzing drawdowns of Fractyl Health Inc. with statistical toolsJuly 2025 Macro Moves & Weekly High Return Opportunities - Newser
Fractyl Health Reports Q2 2025 Financial Results and Progress - MSN
Can volume confirm reversal in Fractyl Health Inc.Trade Exit Summary & Safe Capital Investment Plans - Newser
Will Fractyl Health Inc. stock go up soonJuly 2025 Patterns & Verified Chart Pattern Trade Signals - Newser
Will Fractyl Health Inc. stock recover after recent dropNew Guidance & Verified Momentum Stock Watchlist - Newser
Institutional scanner results for Fractyl Health Inc.2025 Trade Ideas & Safe Entry Momentum Stock Tips - Newser
Will Fractyl Health Inc. Recover After Recent Decline getLinesFromResByArray error: size == 0 - kangso.co.kr
Is now a turning point for Fractyl Health Inc.Trade Exit Summary & Verified Short-Term Plans - Newser
Full technical analysis of Fractyl Health Inc. stock2025 Biggest Moves & Step-by-Step Swing Trade Plans - Newser
Fractyl Health Posts 62% Wider Q2 Loss - AOL.com
Chart overlay techniques for tracking Fractyl Health Inc.Weekly Stock Report & Technical Analysis for Trade Confirmation - Newser
Does Fractyl Health Inc. qualify in momentum factor screeningJuly 2025 Technicals & Low Risk Entry Point Guides - Newser
Is it too late to sell Fractyl Health Inc.Bear Alert & Community Consensus Picks - Newser
Fractyl Health Inc Azioni (GUTS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Fractyl Health Inc Azioni (GUTS) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Barnes Kelly Ann | Director |
Mar 14 '25 |
Buy |
1.30 |
31,000 |
40,210 |
31,000 |
SCHULMAN AMY W | Director |
Mar 13 '25 |
Buy |
1.17 |
8,550 |
9,964 |
8,550 |
BRADLEY WILLIAM | Director |
Mar 13 '25 |
Buy |
1.26 |
16,129 |
20,358 |
16,129 |
Conaway Samuel | Director |
Mar 13 '25 |
Buy |
1.17 |
8,550 |
9,964 |
8,550 |
Rajagopalan Harith | Chief Executive Officer |
Jan 31 '25 |
Option Exercise |
1.70 |
90,972 |
154,652 |
582,301 |
Rajagopalan Harith | Chief Executive Officer |
Jan 30 '25 |
Option Exercise |
1.70 |
20,948 |
35,612 |
512,277 |
Rajagopalan Harith | Chief Executive Officer |
Jan 31 '25 |
Sale |
1.82 |
90,972 |
165,205 |
491,329 |
Rajagopalan Harith | Chief Executive Officer |
Jan 30 '25 |
Sale |
1.95 |
20,948 |
40,798 |
491,329 |
Caplan Jay David | President, Chief Product Off. |
Jan 31 '25 |
Option Exercise |
1.70 |
22,346 |
37,988 |
175,890 |
Caplan Jay David | President, Chief Product Off. |
Jan 30 '25 |
Option Exercise |
1.70 |
21,472 |
36,502 |
175,016 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):